Author:
Pendo Elizabeth,Oliva Jennifer
Abstract
AbstractState prescription drug monitoring programs (PDMPs) use proprietary, predictive software platforms that deploy algorithms to determine whether a patient is at risk for drug misuse, drug diversion, doctor shopping, or substance use disorder (SUD). Clinical overreliance on PDMP algorithm‐generated information and risk scores motivates clinicians to refuse to treat—or to inappropriately treat—vulnerable people based on actual, perceived, or past SUDs, chronic pain conditions, or other disabilities. This essay provides a framework for challenging PDMP algorithmic discrimination as disability discrimination under federal antidiscrimination laws, including a new proposed rule interpreting section 1557 of the Affordable Care Act.
Reference34 articles.
1. Dosing Discrimination: Regulating PDMP Risk Scores;Oliva J. D.;California Law Review,2022
2. “PDMP Policies and Capabilities ” Prescription Drug Monitoring Program Training and Technical Assistance Center (reporting that fifty-one states and territories mandate that prescribers use the PDMP) accessed January 20 2024 https://www.pdmpassist.org/Policies/Maps/PDMPPolicies.
3. 42 U.S.C. 1396w-3a.
4. How prescription drug monitoring programs influence clinical decision-making: A mixed methods systematic review and meta-analysis
5. Substance Use Disorder Discrimination and the CARES Act: Using Disability Law to Inform Part 2 Rulemaking;Dineen K. K.;Arizona State Law Journal,2021